All In MedTech

Company

Uromedica

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.

Private

Latest round: equity, $600K raised of $4.0M sought, first sale Dec 31, 2018, 12 investors.

Funding rounds (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Dec 31, 2018Equity$600K$4.0M12Rule 506(c)Form D ↗Jan 17, 2019

2 more funding rounds with a free account

Company details

From the company's latest Form D.

Legal name
UROMEDICA INC
Headquarters
Plymouth, Minnesota
Incorporated
Minnesota over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    7 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    No 5%+ shareholder filings or SBIR grants found under the name Uromedica.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar
    • NCT04248283 · 167 participants (planned) · Start Jan 26, 2021 · Primary completion May 31, 2027

      Device: Adjustable Continence Therapy for Women (ACT) · For: Urinary Incontinence; Urinary Incontinence,Stress

      Sites: Denver, Colorado; Meridian, Idaho; Independence, Missouri · 8 sites in all

    3 more trials with a free account

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 230100
    Jan 240100
    Feb 240400
    Mar 240300
    Apr 240200
    May 240000
    Jun 240900
    Jul 240400
    Aug 240100
    Sep 240100
    Oct 240000
    Nov 240000
    Dec 241000
    Jan 250100
    Feb 250200
    Mar 250100
    Apr 250400
    May 250100
    Jun 250000
    Jul 250300
    Aug 250000
    Sep 250800
    Oct 250100
    Nov 250000
    Dec 250200
    Jan 260200
    Feb 260000
    Mar 260200
    Apr 260300
    May 260200
    Jun 260200
    Jul 262000
    Aug 260400
    Sep 260100
    Oct 260200
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    The full in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    1 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.